Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelos D Michelakis

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Circulation Research|March 15, 2014
Response to LazarusEvangelos D Michelakis
Circulation Research|February 4, 2006
Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implicationsEvangelos D Michelakis
Circulation|May 14, 2008
Mitochondrial medicine: a new era in medicine opens new windows and brings new challengesEvangelos D Michelakis
Circulation Research|June 22, 2014
Pulmonary arterial hypertension: yesterday, today, tomorrowEvangelos D Michelakis
Heart Failure Reviews|March 26, 2003
The role of the NO axis and its therapeutic implications in pulmonary arterial hypertensionEvangelos D Michelakis
Circulation Research|October 28, 2017
PVDOMICS Drive the Pulmonary Hypertension Field Into the Precision Medicine EraEvangelos D Michelakis
Chest|May 5, 2011
The role of Doppler echocardiography in pulmonary artery hypertension: the importance of proving the obviousIan Paterson, Evangelos D Michelakis
Circulation|August 4, 2012
The estrogen puzzle in pulmonary arterial hypertensionRoxane Paulin, Evangelos D Michelakis
Annual Review of Physiology|November 20, 2012
Mitochondria in vascular health and diseasePeter Dromparis, Evangelos D Michelakis
American Journal of Respiratory and Critical Care Medicine|April 15, 2021
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!Yongneng Zhang, Evangelos D Michelakis
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Circulation Research|March 15, 2014
Response to LazarusEvangelos D Michelakis
Circulation Research|February 4, 2006
Spatio-temporal diversity of apoptosis within the vascular wall in pulmonary arterial hypertension: heterogeneous BMP signaling may have therapeutic implicationsEvangelos D Michelakis
Circulation|May 14, 2008
Mitochondrial medicine: a new era in medicine opens new windows and brings new challengesEvangelos D Michelakis
Circulation Research|June 22, 2014
Pulmonary arterial hypertension: yesterday, today, tomorrowEvangelos D Michelakis
Heart Failure Reviews|March 26, 2003
The role of the NO axis and its therapeutic implications in pulmonary arterial hypertensionEvangelos D Michelakis
Circulation Research|October 28, 2017
PVDOMICS Drive the Pulmonary Hypertension Field Into the Precision Medicine EraEvangelos D Michelakis
Chest|May 5, 2011
The role of Doppler echocardiography in pulmonary artery hypertension: the importance of proving the obviousIan Paterson, Evangelos D Michelakis
Circulation|August 4, 2012
The estrogen puzzle in pulmonary arterial hypertensionRoxane Paulin, Evangelos D Michelakis
Annual Review of Physiology|November 20, 2012
Mitochondria in vascular health and diseasePeter Dromparis, Evangelos D Michelakis
American Journal of Respiratory and Critical Care Medicine|April 15, 2021
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast!Yongneng Zhang, Evangelos D Michelakis
Pageof 12